{"id":29260,"date":"2024-08-23T10:10:02","date_gmt":"2024-08-23T14:10:02","guid":{"rendered":"https:\/\/www.ipoboutique.com\/blog\/?p=29260"},"modified":"2024-08-23T10:10:02","modified_gmt":"2024-08-23T14:10:02","slug":"ipo-pipeline-filings-begin-to-trickle-in-to-set-the-slate-for-september","status":"publish","type":"post","link":"https:\/\/www.ipoboutique.com\/blog\/ipo-pipeline-filings-begin-to-trickle-in-to-set-the-slate-for-september\/","title":{"rendered":"IPO Pipeline: Filings begin to trickle in to set the slate for September"},"content":{"rendered":"<p><span style=\"text-decoration: underline;\"><strong>NEW FILINGS<\/strong><\/span><\/p>\n<p><span style=\"font-weight: 400;\">Company: <\/span><b>Bicara Therapeutics, Inc.<\/b><\/p>\n<p><span style=\"font-weight: 400;\">Symbol: BCAX (Nasdaq)<\/span><\/p>\n<p><span style=\"font-weight: 400;\">Description: They are a clinical-stage biopharmaceutical company committed to bringing transformative bifunctional therapies to patients with solid tumors.<\/span><\/p>\n<p><span style=\"font-weight: 400;\">Shares: TBD<\/span><\/p>\n<p><span style=\"font-weight: 400;\">Price Range: TBD<\/span><\/p>\n<p><span style=\"font-weight: 400;\">Trade Date:\u00a0 TBD<\/span><\/p>\n<p><span style=\"font-weight: 400;\">Underwriters: Morgan Stanley, TD Cowen, Cantor, Stifel<\/span><\/p>\n<p><span style=\"font-weight: 400;\">Link to Prospectus: <\/span><a href=\"https:\/\/www.sec.gov\/Archives\/edgar\/data\/2023658\/000119312524205393\/d821336ds1.htm\"><span style=\"font-weight: 400;\">Filed: 8-22-24<\/span><\/a><\/p>\n<p>&nbsp;<\/p>\n<p><span style=\"font-weight: 400;\">Company: <\/span><b>Zenas BioPharma, Inc.<\/b><\/p>\n<p><span style=\"font-weight: 400;\">Symbol: ZBIO (Nasdaq)<\/span><\/p>\n<p><span style=\"font-weight: 400;\">Description:\u00a0 They are a clinical-stage global biopharmaceutical company committed to being a leader in the development and commercialization of transformative immunology-based therapies for patients in need.<\/span><\/p>\n<p><span style=\"font-weight: 400;\">Shares: TBD<\/span><\/p>\n<p><span style=\"font-weight: 400;\">Price Range: TBD<\/span><\/p>\n<p><span style=\"font-weight: 400;\">Trade Date:\u00a0 TBD<\/span><\/p>\n<p><span style=\"font-weight: 400;\">Underwriters: Morgan Stanley, Jefferies, Citigroup, Guggenheim Securities<\/span><\/p>\n<p><span style=\"font-weight: 400;\">Link to Prospectus: <\/span><a href=\"https:\/\/www.sec.gov\/Archives\/edgar\/data\/1953926\/000110465924091950\/tm2332800-11_s1.htm\"><span style=\"font-weight: 400;\">Filed: 8-22-24<\/span><\/a><\/p>\n<p>&nbsp;<\/p>\n<p><span style=\"font-weight: 400;\">Company: <\/span><b>Brazil Potash Corp.<\/b><\/p>\n<p><span style=\"font-weight: 400;\">Symbol: GRO (NYSE)<\/span><\/p>\n<p><span style=\"font-weight: 400;\">Description:\u00a0 They are a mineral exploration and development company with a potash mining project (which they refer to as the \u201cAutazes Project\u201d) located in the state of Amazonas, Brazil.<\/span><\/p>\n<p><span style=\"font-weight: 400;\">Shares: TBD<\/span><\/p>\n<p><span style=\"font-weight: 400;\">Price Range: TBD<\/span><\/p>\n<p><span style=\"font-weight: 400;\">Trade Date:\u00a0 TBD<\/span><\/p>\n<p><span style=\"font-weight: 400;\">Underwriters: Cantor, Bradesco BBI, Freedom Capital Markets, Roth Capital<\/span><span style=\"font-weight: 400;\"><br \/>\n<\/span><span style=\"font-weight: 400;\">Co-Manager(s): Clarksons Securities<\/span><\/p>\n<p><span style=\"font-weight: 400;\">Link to Prospectus: <\/span><a href=\"https:\/\/www.sec.gov\/Archives\/edgar\/data\/1472326\/000119312524203710\/d303049df1.htm\"><span style=\"font-weight: 400;\">Filed: 8-20-24<\/span><\/a><\/p>\n<p>&nbsp;<\/p>\n<p><span style=\"font-weight: 400;\">Company: <\/span><b>HMH Holding Inc<\/b><\/p>\n<p><span style=\"font-weight: 400;\">Symbol: HMHW (Nasdaq)<\/span><\/p>\n<p><span style=\"font-weight: 400;\">Description:\u00a0 They are a leading provider of highly engineered, mission-critical equipment solutions, providing customers with a comprehensive portfolio of drilling equipment, services and systems utilized in oil and gas drilling operations, both offshore and onshore.\u00a0<\/span><\/p>\n<p><span style=\"font-weight: 400;\">Shares: TBD<\/span><\/p>\n<p><span style=\"font-weight: 400;\">Price Range: TBD<\/span><\/p>\n<p><span style=\"font-weight: 400;\">Trade Date:\u00a0 TBD<\/span><\/p>\n<p><span style=\"font-weight: 400;\">Underwriters: J.P. Morgan, Piper Sandler, Evercore ISI, CItigroup, DNB\u00a0 Markets<\/span><span style=\"font-weight: 400;\"><br \/>\n<\/span><span style=\"font-weight: 400;\">Co-Manager(s): Stifel<\/span><\/p>\n<p><span style=\"font-weight: 400;\">Link to Prospectus: <\/span><a href=\"https:\/\/www.sec.gov\/Archives\/edgar\/data\/2021880\/000119312524198984\/d835350ds1.htm\"><span style=\"font-weight: 400;\">Filed: 8-12-24<\/span><\/a><\/p>\n<p>&nbsp;<\/p>\n","protected":false},"excerpt":{"rendered":"<p>NEW FILINGS Company: Bicara Therapeutics, Inc. Symbol: BCAX (Nasdaq) Description: They are a clinical-stage biopharmaceutical company committed to bringing transformative bifunctional therapies to patients with solid tumors. Shares: TBD Price Range: TBD Trade Date:\u00a0 TBD Underwriters: Morgan Stanley, TD Cowen, Cantor, Stifel Link to Prospectus: Filed: 8-22-24 &nbsp; Company: Zenas BioPharma, Inc. Symbol: ZBIO (Nasdaq)[&hellip;]<\/p>\n","protected":false},"author":4,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"zakra_general_container_width":0,"zakra_general_content_width":0,"zakra_general_sidebar_width":0,"zakra_sticky_header":"customizer","zakra_header_main_area":true,"zakra_site_logo_width":0,"zakra_header_top_enabled":"customizer","zakra_header_top_style":"customizer","zakra_primary_menu_item_style":"customizer","zakra_page_header_text_color":"","zakra_page_header_layout":"customizer","zakra_page_title_bg":null,"zakra_footer_widgets_bg_image":0,"zakra_page_title_bg_repeat":"customizer","zakra_page_title_bg_position":"customizer","zakra_page_title_bg_size":"customizer","zakra_page_title_bg_attachment":"customizer","zakra_breadcrumbs_enabled":"customizer","zakra_breadcrumbs_text_color":null,"zakra_breadcrumbs_separator_color":null,"zakra_breadcrumbs_link_color":null,"zakra_breadcrumbs_link_hover_color":"","zakra_page_title_bg_image":0,"zakra_footer_widgets_enabled":"customizer","zakra_footer_column_layout_1_style":"customizer","zakra_footer_widgets_bg":"","zakra_footer_widgets_bg_repeat":"customizer","zakra_footer_widgets_bg_position":"customizer","zakra_footer_widgets_bg_size":"customizer","zakra_footer_widgets_bg_attachment":"customizer","zakra_footer_bar_enabled":"customizer","zakra_footer_bar_style":"customizer","footnotes":""},"categories":[1536],"tags":[],"class_list":["post-29260","post","type-post","status-publish","format-standard","hentry","category-subscriber-content"],"_links":{"self":[{"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/posts\/29260","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/comments?post=29260"}],"version-history":[{"count":1,"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/posts\/29260\/revisions"}],"predecessor-version":[{"id":29261,"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/posts\/29260\/revisions\/29261"}],"wp:attachment":[{"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/media?parent=29260"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/categories?post=29260"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/tags?post=29260"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}